Silibinin mode of action(s) against HCV: A controversy yet to be resolved

Eitemau Tebyg

• Understanding silibinin’s modes of action against HCV using viral kinetic modeling
  gan: Guedj, Jeremie, et al.
  Cyhoeddwyd: (2012)
• The rapid viral decline with the HCV NS5A inhibitor daclatasvir reveals a dual mode of action and leads to a new HCV half-life estimate
  gan: Guedj, Jeremie, et al.
  Cyhoeddwyd: (2013)
• Understanding the nature of early HCV RNA blips and the use of mathematical modeling of viral kinetics during IFN-based therapy
  gan: Guedj, Jeremie, et al.
  Cyhoeddwyd: (2011)
• A Perspective on Modeling Hepatitis C Virus Infection
  gan: Guedj, Jeremie, et al.
  Cyhoeddwyd: (2010)
• Treatment of hepatitis C with an interferon-based lead-in phase: A perspective from mathematical modeling
  gan: Rong, Libin, et al.
  Cyhoeddwyd: (2014)